There are 15,358 results relating to "Medicin Viagra-m"
Order by
|
Questions and Answers
Date answered:
4 October 2010
S3W-36568
The bodies with responsibility for providing advice about newly licensed medicines and new technologies remain the Scottish Medicines Consortium and the Scottish Health Technologies Group respectively.
Questions and Answers
Date answered:
5 October 2009
S3W-27698
The Scottish Government is preparing guidance which sets out the policy framework with regard to the introduction and availability of new medicines in the NHS in Scotland. Work is progressing on the draft guidance, which will be tested with NHS boards and stakeholders.
Questions and Answers
Date answered:
25 September 2009
S3W-27448
The Gross Ingredient Costs given relate to medicines dispensed in the community and do not include the cost of medicines dispensed in hospitals or in hospital-based clinics.
Questions and Answers
Date answered:
21 July 2009
S3W-25346
The Department of Health uses the quarterly information it receives relating to sales of branded medicines to monitor the impact of changes to the supply chain.
Questions and Answers
Date answered:
26 February 2008
S3W-09167
The MHRA continuously monitor the safety of medicines and devices on the UK market.
Official Report
Meeting date:
24 June 2014
Health and Sport Committee 24 June 2014
How do people get medicines without having to go to the general practitioner all the time?
Official Report
Meeting date:
18 November 2025
Health, Social Care and Sport Committee 18 November 2025
A law that changes the relationship between medicine and mortality cannot simply be left to drift; it must be re-earned through evidence and accountability.
Questions and Answers
Date answered:
7 February 2011
S3W-39123
The extant guidance on NHS availability of complementary and alternative medicine therapies is the guidance issued to NHS boards in August 2005.
Questions and Answers
Date answered:
19 November 2009
S3W-28278
The Scottish Government is preparing guidance for NHS boards which sets out the policy framework with regard to the introduction and availability of new medicines in the NHS in Scotland and includes a specific requirement for NHS boards to have fair, consistent and systematic processes for requests for medicines to b...
Questions and Answers
Date answered:
5 October 2009
S3W-27686
The report Improving access to new medicines for NHS patients by Professor Mike Richards was commissioned by the Secretary of State for Health.
